Europe Monoclonal Antibodies In Veterinary Health Market Size, Share & Industry Analysis Report By Animal Type, By Scope, By End User, By Country and Growth Forecast, 2025

List of Tables

The Europe Monoclonal Antibodies In Veterinary Health Market would witness market growth of 18.3% CAGR during the forecast period (2025-2032).

The Germany market dominated the Europe Monoclonal Antibodies In Veterinary Health Market by Country in 2024, and would continue to be a dominant market till 2032; thereby, achieving a market value of $216.2 million by 2032. The UK market is exhibiting a CAGR of 16.9% during (2025 - 2032). Additionally, The France market would experience a CAGR of 19.1% during (2025 - 2032).

The European veterinary healthcare landscape has undergone a significant transformation over the past decade, with monoclonal antibodies (mAbs) emerging as a pivotal innovation in animal therapeutics. Initially developed for human medicine, mAbs are laboratory-engineered molecules designed to target specific antigens. Their precision and efficacy have now been successfully adapted to veterinary medicine, marking a turning point in the treatment of chronic and complex animal diseases.

The journey of monoclonal antibodies in European veterinary health began as part of a broader shift toward biologics, which are biotechnological products derived from living organisms. Their introduction was driven by the growing demand for targeted, safe, and long-lasting treatments for conditions such as allergic dermatitis, osteoarthritis, and chronic inflammation in companion animals. Traditional pharmaceuticals, often limited by systemic side effects or short efficacy windows, created a gap that mAbs have started to fill effectively.

Germany represents one of the most advanced veterinary markets in Europe, underpinned by high pet ownership, strong veterinary infrastructure, and substantial investment in animal healthcare. As a leader in both agricultural production and companion animal welfare, Germany is positioned well for rapid adoption of monoclonal antibodies (mAbs) in veterinary use. German veterinarians and pet owners increasingly seek precision-targeted treatments-especially for chronic conditions such as osteoarthritis, atopic dermatitis, and certain cancers. The nation's robust biotech sector, known for its human biologics expertise, is now pivoting toward veterinary applications.

The UK veterinary market for mAbs is among the most progressive in Europe, shaped by high companion animal ownership and a cultural tendency to treat pets akin to family. The strong human biologics sector in the UK-including established antibody platforms-offers a significant competitive advantage when transitioning to veterinary applications. Regulatory structures, such as the VMD underpinned by EMA guidance, ensure high safety and efficacy standards, boosting stakeholder confidence in novel treatments.

France's veterinary mAb market benefits from high per capita pet ownership and strong animal welfare traditions. The French veterinary system blends public accountability with private clinic capacities, which are well poised to adopt biologics. Veterinary schools-such as those in Lyon and Toulouse-have begun pilot research into anti NGF therapeutics and monoclonal diagnostics for infectious diseases. In conclusion, Europe's structured regulatory support and early adoption of biologics have positioned it as a mature and steadily growing market for veterinary monoclonal antibodies.

Based on Animal Type, the market is segmented into Dogs and Other Animal Type. Based on Scope, the market is segmented into Dermatology, Pain, and Other Scope. Based on End User, the market is segmented into Veterinary Hospitals and Other End User. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

List of Key Companies Profiled

Zoetis, Inc.
Virbac
Merck KGaA
Elanco Animal Health, Inc.
Boehringer Ingelheim International GmbH
Ceva Sante Animale
Phibro Animal Health Corporation
Indian Immunologicals Ltd.

Europe Monoclonal Antibodies In Veterinary Health Market Report Segmentation

By Animal Type

Dogs
Other Animal Type

By Scope

Dermatology
Pain
Other Scope

By End User

Veterinary Hospitals
Other End User

By Country

Germany
UK
France
Russia
Spain
Italy
Rest of Europe

Chapter 1. Market Scope & Methodology

1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
- 1.4.1 Europe Monoclonal Antibodies In Veterinary Health Market, by Animal Type
- 1.4.2 Europe Monoclonal Antibodies In Veterinary Health Market, by Scope
- 1.4.3 Europe Monoclonal Antibodies In Veterinary Health Market, by End User
- 1.4.4 Europe Monoclonal Antibodies In Veterinary Health Market, by Country
1.5 Methodology for the research

Chapter 2. Market at a Glance

2.1 Key Highlights

Chapter 3. Market Overview

3.1 Introduction
- 3.1.1 Overview
  - 3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
- 3.2.1 Market Drivers
- 3.2.2 Market Restraints
- 3.2.3 Market Opportunities
- 3.2.4 Market Challenges
3.3 Porter Five Forces Analysis

Chapter 4. Value Chain Analysis of Monoclonal Antibodies In Veterinary Health Market

4.1 Research & Development (R&D)
4.2 Regulatory & Clinical Trials
4.3 Technology Transfer & Process Validation
4.4 Manufacturing
4.5 Packaging & Distribution
4.6 Marketing & Veterinary Engagement
4.7 Post-Market Surveillance & Pharmacovigilance
4.8 Customer Feedback & Support

Chapter 5. Key Costumer Criteria - Monoclonal Antibodies In Veterinary Health Market

Chapter 6. Europe Monoclonal Antibodies In Veterinary Health Market by Animal Type

6.1 Europe Dogs Market by Country
6.2 Europe Other Animal Type Market by Country

Chapter 7. Europe Monoclonal Antibodies In Veterinary Health Market by Scope

7.1 Europe Dermatology Market by Country
7.2 Europe Pain Market by Country
7.3 Europe Other Scope Market by Country

Chapter 8. Europe Monoclonal Antibodies In Veterinary Health Market by End User

8.1 Europe Veterinary Hospitals Market by Country
8.2 Europe Other End User Market by Country

Chapter 9. Europe Monoclonal Antibodies In Veterinary Health Market by Country

9.1 Germany Monoclonal Antibodies In Veterinary Health Market
- 9.1.1 Germany Monoclonal Antibodies In Veterinary Health Market by Animal Type
- 9.1.2 Germany Monoclonal Antibodies In Veterinary Health Market by Scope
- 9.1.3 Germany Monoclonal Antibodies In Veterinary Health Market by End User
9.2 UK Monoclonal Antibodies In Veterinary Health Market
- 9.2.1 UK Monoclonal Antibodies In Veterinary Health Market by Animal Type
- 9.2.2 UK Monoclonal Antibodies In Veterinary Health Market by Scope
- 9.2.3 UK Monoclonal Antibodies In Veterinary Health Market by End User
9.3 France Monoclonal Antibodies In Veterinary Health Market
- 9.3.1 France Monoclonal Antibodies In Veterinary Health Market by Animal Type
- 9.3.2 France Monoclonal Antibodies In Veterinary Health Market by Scope
- 9.3.3 France Monoclonal Antibodies In Veterinary Health Market by End User
9.4 Russia Monoclonal Antibodies In Veterinary Health Market
- 9.4.1 Russia Monoclonal Antibodies In Veterinary Health Market by Animal Type
- 9.4.2 Russia Monoclonal Antibodies In Veterinary Health Market by Scope
- 9.4.3 Russia Monoclonal Antibodies In Veterinary Health Market by End User
9.5 Spain Monoclonal Antibodies In Veterinary Health Market
- 9.5.1 Spain Monoclonal Antibodies In Veterinary Health Market by Animal Type
- 9.5.2 Spain Monoclonal Antibodies In Veterinary Health Market by Scope
- 9.5.3 Spain Monoclonal Antibodies In Veterinary Health Market by End User
9.6 Italy Monoclonal Antibodies In Veterinary Health Market
- 9.6.1 Italy Monoclonal Antibodies In Veterinary Health Market by Animal Type
- 9.6.2 Italy Monoclonal Antibodies In Veterinary Health Market by Scope
- 9.6.3 Italy Monoclonal Antibodies In Veterinary Health Market by End User
9.7 Rest of Europe Monoclonal Antibodies In Veterinary Health Market
- 9.7.1 Rest of Europe Monoclonal Antibodies In Veterinary Health Market by Animal Type
- 9.7.2 Rest of Europe Monoclonal Antibodies In Veterinary Health Market by Scope
- 9.7.3 Rest of Europe Monoclonal Antibodies In Veterinary Health Market by End User

Chapter 10. Company Profiles

10.1 Zoetis, Inc.
- 10.1.1 Company Overview
- 10.1.2 Financial Analysis
- 10.1.3 Regional Analysis
- 10.1.4 Research & Development Expenses
- 10.1.5 Recent strategies and developments:
  - 10.1.5.1 Product Launches and Product Expansions:
- 10.1.6 SWOT Analysis
10.2 Virbac
- 10.2.1 Company Overview
- 10.2.2 Financial Analysis
- 10.2.3 Regional Analysis
- 10.2.4 Recent strategies and developments:
  - 10.2.4.1 Partnerships, Collaborations, and Agreements:
- 10.2.5 SWOT Analysis
10.3 Merck KGaA
- 10.3.1 Company Overview
- 10.3.2 Financial Analysis
- 10.3.3 Segmental and Regional Analysis
- 10.3.4 Research & Development Expenses
- 10.3.5 SWOT Analysis
10.4 Elanco Animal Health, Inc.
- 10.4.1 Company Overview
- 10.4.2 Financial Analysis
- 10.4.3 Regional Analysis
- 10.4.4 Research & Development Expenses
- 10.4.5 SWOT Analysis
10.5 Boehringer Ingelheim International GmbH
- 10.5.1 Company Overview
- 10.5.2 Financial Analysis
- 10.5.3 Segmental and Regional Analysis
- 10.5.4 Research & Development Expenses
- 10.5.5 SWOT Analysis
10.6 Ceva Sante Animale
- 10.6.1 Company Overview
- 10.6.2 SWOT Analysis
10.7 Phibro Animal Health Corporation
- 10.7.1 Company Overview
- 10.7.2 Financial Analysis
- 10.7.3 Segmental and Regional Analysis
- 10.7.4 Research & Development Expenses
10.8 Indian Immunologicals Ltd.
- 10.8.1 Company Overview

LIST OF TABLES

TABLE 1 Europe Monoclonal Antibodies In Veterinary Health Market, 2021 - 2024, USD Million
TABLE 2 Europe Monoclonal Antibodies In Veterinary Health Market, 2025 - 2032, USD Million
TABLE 3 Key Costumer Criteria - Monoclonal Antibodies In Veterinary Health Market
TABLE 4 Europe Monoclonal Antibodies In Veterinary Health Market by Animal Type, 2021 - 2024, USD Million
TABLE 5 Europe Monoclonal Antibodies In Veterinary Health Market by Animal Type, 2025 - 2032, USD Million
TABLE 6 Europe Dogs Market by Country, 2021 - 2024, USD Million
TABLE 7 Europe Dogs Market by Country, 2025 - 2032, USD Million
TABLE 8 Europe Other Animal Type Market by Country, 2021 - 2024, USD Million
TABLE 9 Europe Other Animal Type Market by Country, 2025 - 2032, USD Million
TABLE 10 Use Case 1: Canine Monoclonal Antibody Therapies - Targeted Treatment Innovations for Dogs
TABLE 11 Use Case 2: Monoclonal Antibodies for Livestock & Exotic Animals - Immune-Driven Disease Control
TABLE 12 Europe Monoclonal Antibodies In Veterinary Health Market by Scope, 2021 - 2024, USD Million
TABLE 13 Europe Monoclonal Antibodies In Veterinary Health Market by Scope, 2025 - 2032, USD Million
TABLE 14 Europe Dermatology Market by Country, 2021 - 2024, USD Million
TABLE 15 Europe Dermatology Market by Country, 2025 - 2032, USD Million
TABLE 16 Europe Pain Market by Country, 2021 - 2024, USD Million
TABLE 17 Europe Pain Market by Country, 2025 - 2032, USD Million
TABLE 18 Europe Other Scope Market by Country, 2021 - 2024, USD Million
TABLE 19 Europe Other Scope Market by Country, 2025 - 2032, USD Million
TABLE 20 Use Case 1: Targeted Monoclonal Antibody Therapy for Canine Dermatological Conditions
TABLE 21 Use Case 2: Monoclonal Antibody-Based Pain Management in Veterinary Orthopedic Care
TABLE 22 Use Case 3: Monoclonal Antibodies for Veterinary Oncology, Immune Modulation & Infectious Disease
TABLE 23 Europe Monoclonal Antibodies In Veterinary Health Market by End User, 2021 - 2024, USD Million
TABLE 24 Europe Monoclonal Antibodies In Veterinary Health Market by End User, 2025 - 2032, USD Million
TABLE 25 Europe Veterinary Hospitals Market by Country, 2021 - 2024, USD Million
TABLE 26 Europe Veterinary Hospitals Market by Country, 2025 - 2032, USD Million
TABLE 27 Europe Other End User Market by Country, 2021 - 2024, USD Million
TABLE 28 Europe Other End User Market by Country, 2025 - 2032, USD Million
TABLE 29 Europe Monoclonal Antibodies In Veterinary Health Market by Country, 2021 - 2024, USD Million
TABLE 30 Europe Monoclonal Antibodies In Veterinary Health Market by Country, 2025 - 2032, USD Million
TABLE 31 Germany Monoclonal Antibodies In Veterinary Health Market, 2021 - 2024, USD Million
TABLE 32 Germany Monoclonal Antibodies In Veterinary Health Market, 2025 - 2032, USD Million
TABLE 33 Germany Monoclonal Antibodies In Veterinary Health Market by Animal Type, 2021 - 2024, USD Million
TABLE 34 Germany Monoclonal Antibodies In Veterinary Health Market by Animal Type, 2025 - 2032, USD Million
TABLE 35 Germany Monoclonal Antibodies In Veterinary Health Market by Scope, 2021 - 2024, USD Million
TABLE 36 Germany Monoclonal Antibodies In Veterinary Health Market by Scope, 2025 - 2032, USD Million
TABLE 37 Germany Monoclonal Antibodies In Veterinary Health Market by End User, 2021 - 2024, USD Million
TABLE 38 Germany Monoclonal Antibodies In Veterinary Health Market by End User, 2025 - 2032, USD Million
TABLE 39 UK Monoclonal Antibodies In Veterinary Health Market, 2021 - 2024, USD Million
TABLE 40 UK Monoclonal Antibodies In Veterinary Health Market, 2025 - 2032, USD Million
TABLE 41 UK Monoclonal Antibodies In Veterinary Health Market by Animal Type, 2021 - 2024, USD Million
TABLE 42 UK Monoclonal Antibodies In Veterinary Health Market by Animal Type, 2025 - 2032, USD Million
TABLE 43 UK Monoclonal Antibodies In Veterinary Health Market by Scope, 2021 - 2024, USD Million
TABLE 44 UK Monoclonal Antibodies In Veterinary Health Market by Scope, 2025 - 2032, USD Million
TABLE 45 UK Monoclonal Antibodies In Veterinary Health Market by End User, 2021 - 2024, USD Million
TABLE 46 UK Monoclonal Antibodies In Veterinary Health Market by End User, 2025 - 2032, USD Million
TABLE 47 France Monoclonal Antibodies In Veterinary Health Market, 2021 - 2024, USD Million
TABLE 48 France Monoclonal Antibodies In Veterinary Health Market, 2025 - 2032, USD Million
TABLE 49 France Monoclonal Antibodies In Veterinary Health Market by Animal Type, 2021 - 2024, USD Million
TABLE 50 France Monoclonal Antibodies In Veterinary Health Market by Animal Type, 2025 - 2032, USD Million
TABLE 51 France Monoclonal Antibodies In Veterinary Health Market by Scope, 2021 - 2024, USD Million
TABLE 52 France Monoclonal Antibodies In Veterinary Health Market by Scope, 2025 - 2032, USD Million
TABLE 53 France Monoclonal Antibodies In Veterinary Health Market by End User, 2021 - 2024, USD Million
TABLE 54 France Monoclonal Antibodies In Veterinary Health Market by End User, 2025 - 2032, USD Million
TABLE 55 Russia Monoclonal Antibodies In Veterinary Health Market, 2021 - 2024, USD Million
TABLE 56 Russia Monoclonal Antibodies In Veterinary Health Market, 2025 - 2032, USD Million
TABLE 57 Russia Monoclonal Antibodies In Veterinary Health Market by Animal Type, 2021 - 2024, USD Million
TABLE 58 Russia Monoclonal Antibodies In Veterinary Health Market by Animal Type, 2025 - 2032, USD Million
TABLE 59 Russia Monoclonal Antibodies In Veterinary Health Market by Scope, 2021 - 2024, USD Million
TABLE 60 Russia Monoclonal Antibodies In Veterinary Health Market by Scope, 2025 - 2032, USD Million
TABLE 61 Russia Monoclonal Antibodies In Veterinary Health Market by End User, 2021 - 2024, USD Million
TABLE 62 Russia Monoclonal Antibodies In Veterinary Health Market by End User, 2025 - 2032, USD Million
TABLE 63 Spain Monoclonal Antibodies In Veterinary Health Market, 2021 - 2024, USD Million
TABLE 64 Spain Monoclonal Antibodies In Veterinary Health Market, 2025 - 2032, USD Million
TABLE 65 Spain Monoclonal Antibodies In Veterinary Health Market by Animal Type, 2021 - 2024, USD Million
TABLE 66 Spain Monoclonal Antibodies In Veterinary Health Market by Animal Type, 2025 - 2032, USD Million
TABLE 67 Spain Monoclonal Antibodies In Veterinary Health Market by Scope, 2021 - 2024, USD Million
TABLE 68 Spain Monoclonal Antibodies In Veterinary Health Market by Scope, 2025 - 2032, USD Million
TABLE 69 Spain Monoclonal Antibodies In Veterinary Health Market by End User, 2021 - 2024, USD Million
TABLE 70 Spain Monoclonal Antibodies In Veterinary Health Market by End User, 2025 - 2032, USD Million
TABLE 71 Italy Monoclonal Antibodies In Veterinary Health Market, 2021 - 2024, USD Million
TABLE 72 Italy Monoclonal Antibodies In Veterinary Health Market, 2025 - 2032, USD Million
TABLE 73 Italy Monoclonal Antibodies In Veterinary Health Market by Animal Type, 2021 - 2024, USD Million
TABLE 74 Italy Monoclonal Antibodies In Veterinary Health Market by Animal Type, 2025 - 2032, USD Million
TABLE 75 Italy Monoclonal Antibodies In Veterinary Health Market by Scope, 2021 - 2024, USD Million
TABLE 76 Italy Monoclonal Antibodies In Veterinary Health Market by Scope, 2025 - 2032, USD Million
TABLE 77 Italy Monoclonal Antibodies In Veterinary Health Market by End User, 2021 - 2024, USD Million
TABLE 78 Italy Monoclonal Antibodies In Veterinary Health Market by End User, 2025 - 2032, USD Million
TABLE 79 Rest of Europe Monoclonal Antibodies In Veterinary Health Market, 2021 - 2024, USD Million
TABLE 80 Rest of Europe Monoclonal Antibodies In Veterinary Health Market, 2025 - 2032, USD Million
TABLE 81 Rest of Europe Monoclonal Antibodies In Veterinary Health Market by Animal Type, 2021 - 2024, USD Million
TABLE 82 Rest of Europe Monoclonal Antibodies In Veterinary Health Market by Animal Type, 2025 - 2032, USD Million
TABLE 83 Rest of Europe Monoclonal Antibodies In Veterinary Health Market by Scope, 2021 - 2024, USD Million
TABLE 84 Rest of Europe Monoclonal Antibodies In Veterinary Health Market by Scope, 2025 - 2032, USD Million
TABLE 85 Rest of Europe Monoclonal Antibodies In Veterinary Health Market by End User, 2021 - 2024, USD Million
TABLE 86 Rest of Europe Monoclonal Antibodies In Veterinary Health Market by End User, 2025 - 2032, USD Million
TABLE 87 Key Information - Zoetis, Inc.
TABLE 88 Key Information - Virbac
TABLE 89 key Information - Merck KGaA
TABLE 90 Key information - Elanco Animal Health, Inc.
TABLE 91 Key Information - Boehringer Ingelheim International GmbH
TABLE 92 Key Information - Ceva SantE Animale
TABLE 93 Key Information - Phibro Animal Health Corporation
TABLE 94 Key Information - Indian Immunologicals Ltd

LIST OF FIGURES

FIG 1 Methodology for the research
FIG 2 Europe Monoclonal Antibodies In Veterinary Health Market, 2021 - 2032, USD Million
FIG 3 Key Factors Impacting Monoclonal Antibodies In Veterinary Health Market
FIG 4 Porter's Five Forces Analysis - Monoclonal Antibodies In Veterinary Health Market
FIG 5 Value Chain Analysis of Monoclonal Antibodies In Veterinary Health Market
FIG 6 Key Costumer Criteria - Monoclonal Antibodies In Veterinary Health Market
FIG 7 Europe Monoclonal Antibodies In Veterinary Health Market share by Animal Type, 2024
FIG 8 Europe Monoclonal Antibodies In Veterinary Health Market share by Animal Type, 2032
FIG 9 Europe Monoclonal Antibodies In Veterinary Health Market by Animal Type, 2021 - 2032, USD Million
FIG 10 Europe Monoclonal Antibodies In Veterinary Health Market share by Scope, 2024
FIG 11 Europe Monoclonal Antibodies In Veterinary Health Market share by Scope, 2032
FIG 12 Europe Monoclonal Antibodies In Veterinary Health Market by Scope, 2021 - 2032, USD Million
FIG 13 Europe Monoclonal Antibodies In Veterinary Health Market share by End User, 2024
FIG 14 Europe Monoclonal Antibodies In Veterinary Health Market share by End User, 2032
FIG 15 Europe Monoclonal Antibodies In Veterinary Health Market by End User, 2021 - 2032, USD Million
FIG 16 Europe Monoclonal Antibodies In Veterinary Health Market share by Country, 2024
FIG 17 Europe Monoclonal Antibodies In Veterinary Health Market by Country, 2032
FIG 18 Europe Monoclonal Antibodies In Veterinary Health Market by Country, 2021 - 2032, USD Million
FIG 19 Swot Analysis: ZOETIS, INC.
FIG 20 SWOT Analysis: Virbac
FIG 21 Swot Analysis: Merck KGaA
FIG 22 SWOT Analysis: Elanco Animal Health, Inc.
FIG 23 SWOT Analysis: Boehringer Ingelheim International GmbH
FIG 24 SWOT Analysis: Ceva Sante Animale

Europe Monoclonal Antibodies In Veterinary Health Market Size, Share & Industry Analysis Report By Animal Type, By Scope, By End User, By Country and Growth Forecast, 2025 - 2032

Description

Table of Contents